AQR Arbitrage’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-75,000
Closed -$6K 1469
2022
Q3
$6K Hold
75,000
﹤0.01% 1246
2022
Q2
$7K Hold
75,000
﹤0.01% 1312
2022
Q1
$26K Hold
75,000
﹤0.01% 1070
2021
Q4
$728K Hold
75,000
0.02% 769
2021
Q3
$43K Hold
75,000
﹤0.01% 942
2021
Q2
$53K Buy
+75,000
New +$42.5K ﹤0.01% 937

Other funds holding EQHA.WS

AQR Arbitrage's EQHA.WS Position: Q4 2022 in Review

AQR Arbitrage sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 75,000 shares — an estimated $6K sold.

AQR Arbitrage first reported a position in EQHA.WS in Q2 2021 and held it in 6 quarters. The position peaked at $728K in Q4 2021. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

  • AQR Arbitrage reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • AQR Arbitrage sold 75,000 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $6K.
  • AQR Arbitrage first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q2 2021 and held it in 6 quarters.
  • AQR Arbitrage's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $728K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on AQR Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.